UnitedHealth Group Incorporated (UNH) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $407.71 (-0.75%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 2, 2026 | David MacDonald | Truist Financial | $370.00 | -9.2% |
| Jan 30, 2026 | Stephen Baxter | Wells Fargo | $370.00 | -9.2% |
| Jan 30, 2026 | Andrew Mok | Barclays | $327.00 | -19.8% |
| Jan 28, 2026 | Michael Wiederhorn | Oppenheimer | $385.00 | -5.6% |
| Jan 28, 2026 | Erin Wright | Morgan Stanley | $375.00 | -8.0% |
| Jan 25, 2026 | Erin Wright | Morgan Stanley | $409.00 | +0.3% |
| Jan 6, 2026 | Elizabeth Anderson | Evercore ISI | $400.00 | -1.9% |
| Jan 5, 2026 | Andrew Mok | Barclays | $391.00 | -4.1% |
| Oct 29, 2025 | Ben Hendrix | RBC Capital | $408.00 | +0.1% |
| Oct 29, 2025 | Whit Mayo | Leerink Partners | $410.00 | +0.6% |
| Oct 28, 2025 | Jessica Tassan | Piper Sandler | $417.00 | +2.3% |
| Oct 17, 2025 | David Windley | Jefferies | $409.00 | +0.3% |
| Oct 9, 2025 | Andrew Mok | Barclays | $386.00 | -5.3% |
| Sep 4, 2025 | Andrew Mok | Barclays | $352.00 | -13.7% |
| Sep 4, 2025 | Andrew Mok | Barclays | $362.00 | -11.2% |
| May 21, 2025 | Sidharth Sahoo | HSBC | $270.00 | -33.8% |
| May 20, 2025 | Justin Lake | Wolfe Research | $390.00 | -4.3% |
| May 19, 2025 | David MacDonald | Truist Financial | $360.00 | -11.7% |
| May 16, 2025 | Ann Hynes | Mizuho Securities | $350.00 | -14.2% |
| May 16, 2025 | Ben Hendrix | RBC Capital | $355.00 | -12.9% |
Top Analysts Covering UNH
UNH vs Sector & Market
| Metric | UNH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.09 | 2.24 | 2.41 |
| Analyst Count | 35 | 8 | 19 |
| Target Upside | +2.6% | +11475.0% | +17.1% |
| P/E Ratio | 31.11 | 4.00 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $441.31B | $443.30B | $446.84B | 12 |
| 2027-03-31 | $109.53B | $111.20B | $114.28B | 11 |
| 2027-06-30 | $111.50B | $113.20B | $116.34B | 7 |
| 2027-09-30 | $112.73B | $114.45B | $117.62B | 8 |
| 2027-12-31 | $113.76B | $115.50B | $118.69B | 7 |
| 2028-03-31 | $116.15B | $117.93B | $121.19B | 6 |
| 2028-06-30 | $118.52B | $120.33B | $123.66B | 6 |
| 2028-09-30 | $119.49B | $121.31B | $124.67B | 11 |
| 2028-12-31 | $120.83B | $122.67B | $126.07B | 6 |
| 2029-12-31 | $507.25B | $513.60B | $529.35B | 11 |
| 2030-12-31 | $541.49B | $548.27B | $565.08B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16.85 | $18.27 | $18.84 | 20 |
| 2027-03-31 | $7.48 | $7.63 | $7.90 | 10 |
| 2027-06-30 | $5.23 | $5.34 | $5.53 | 7 |
| 2027-09-30 | $4.19 | $4.27 | $4.43 | 7 |
| 2027-12-31 | $3.24 | $3.31 | $3.43 | 14 |
| 2028-03-31 | $8.41 | $8.57 | $8.88 | 11 |
| 2028-06-30 | $6.11 | $6.24 | $6.46 | 8 |
| 2028-09-30 | $4.95 | $5.05 | $5.23 | 8 |
| 2028-12-31 | $3.80 | $3.87 | $4.01 | 15 |
| 2029-12-31 | $28.35 | $28.81 | $29.96 | 4 |
| 2030-12-31 | $32.43 | $32.96 | $34.27 | 4 |
Frequently Asked Questions
What is the analyst consensus for UNH?
The consensus among 35 analysts covering UnitedHealth Group Incorporated (UNH) is Buy with an average price target of $385.38.
What is the highest price target for UNH?
The highest price target for UNH is $675.00, set by Matthew Gillmor at KeyBanc on 2024-10-10.
What is the lowest price target for UNH?
The lowest price target for UNH is $270.00, set by Sidharth Sahoo at HSBC on 2025-05-21.
How many analysts cover UNH?
35 analysts have issued ratings for UnitedHealth Group Incorporated in the past 12 months.
Is UNH a buy or sell right now?
Based on 35 analyst ratings, UNH has a consensus rating of Buy (2.09/5) with a +2.6% upside to the consensus target of $385.38.
What are the earnings estimates for UNH?
Analysts estimate UNH will report EPS of $18.27 for the period ending 2026-12-31, with revenue estimated at $443.30B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.